SCHEMBL27211489

SCHEMBL27211489

Nc1ccn2c(C(=O)c3ccc(Cl)cc3)c(C(=O)O)c(C(=O)O)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ FNTA P49354 1/20 0.42
▸ FNTB P49356 1/20 0.42
▸ SRD5A2 P31213 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.40
▸ NR4A1 P22736 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ UCHL1 P09936 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27211514 0.84 CA1 (0.42) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL30883371 0.83 KDM4E (0.51) MAPTNPSR1POLBCYP1A2CYP2D6
SCHEMBL30883372 0.83 KDM4E (0.51) MAPTNPSR1POLBCYP1A2CYP2D6
SCHEMBL27211504 0.73 RXFP1 (0.43) MAPTPOLBRXFP1MEN1ALDH1A1
SCHEMBL30883370 0.70 KDM4E (0.51) MAPTNPSR1L3MBTL1MEN1ALDH1A1
SCHEMBL27165735 0.67 FNTA (0.42) MAPTFNTAFNTBSRD5A2CYP1A2
SCHEMBL27181989 0.67 DHODH (0.40) MAPTNPSR1POLBFNTAFNTB
SCHEMBL4747566 0.64 SRD5A2 (0.64) MAPTSRD5A2L3MBTL1NR4A1MEN1
SCHEMBL27676963 0.63 SRD5A2 (0.57) MAPTSRD5A2L3MBTL1NR4A1MEN1
SCHEMBL11756977 0.63 SRD5A2 (0.63) SRD5A2NR4A1ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents King Faisal University (SA) 2024-05-07 — — US claimed
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents King Faisal University (SA) 2024-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11976066-B1 Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents BET1, INMT, IDO1 MAPT 1135/4885NPSR1 4059/4885POLB 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback